Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMYD3 | Q9H7B4 | 4/20 | 0.38 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | JAK2 | O60674 | 1/20 | 0.35 |
| ▸ | JAK1 | P23458 | 1/20 | 0.35 |
| ▸ | JAK3 | P52333 | 1/20 | 0.35 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2696428 | 0.87 | NPC1 (0.42) | EGLN1NPC1RAB9ASMYD3IRAK4 | |
| SCHEMBL2693737 | 0.87 | IRAK4 (0.37) | EGLN1NPC1RAB9ASMYD3IRAK4 | |
| SCHEMBL2695326 | 0.85 | EGLN1 (0.42) | EGLN1NPC1RAB9ASMYD3IRAK4 | |
| SCHEMBL2695475 | 0.81 | NPC1 (0.48) | NPC1RAB9ASMYD3P2RX7JAK2 | |
| SCHEMBL3140934 | 0.78 | EGLN1 (0.35) | EGLN1 | |
| SCHEMBL2696430 | 0.77 | NPC1 (0.44) | EGLN1NPC1RAB9ASMYD3IRAK4 | |
| SCHEMBL2693742 | 0.77 | IRAK4 (0.40) | EGLN1NPC1RAB9ASMYD3IRAK4 | |
| SCHEMBL2905901 | 0.75 | CXCR5 (0.34) | — | |
| SCHEMBL2780136 | 0.75 | IRAK4 (0.41) | EGLN1IRAK4 | |
| SCHEMBL2694672 | 0.73 | NPC1 (0.52) | NPC1RAB9ASMYD3P2RX7JAK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3646731-A1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-05-06 | — | — | EP | claimed |
| EP-3300602-B1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-03-25 | — | — | EP | claimed |
| EP-3300602-A1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2018-04-04 | — | — | EP | claimed |
| US-20160219872-A1 | Foamable Pesticide Compositions And Methods Of Application | BASF CORPORATION | 2016-08-04 | — | — | US | claimed |
| US-9339030-B2 | Foamable pesticide compositions and methods of application | BASF CORPORATION (US) | 2016-05-17 | — | — | US | claimed |
| EP-2864320-A1 | PYRAZOLE COMPOUND AND PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2015-04-29 | — | — | EP | claimed |
| US-20150105258-A1 | Methods For Controlling Pests | BASF CORPORATION (US) | 2015-04-16 | — | — | US | claimed |
| US-8980294-B2 | Methods for controlling pests | BASF CORPORATION (US) | 2015-03-17 | — | — | US | claimed |
| US-8940662-B2 | Methods for controlling pests | BASF CORPORATION (US) | 2015-01-27 | — | — | US | claimed |
| WO-2014063942-A1 | SUBSTITUTED PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2014-05-01 | — | — | WO | claimed |
| EP-2654424-A1 | PESTICIDAL ACTIVE MIXTURES COMPRISING PYRAZOLE COMPOUNDS | BASF SE (DE) | 2013-10-30 | — | — | EP | claimed |
| WO-2013156318-A1 | SUBSTITUTED PESTICIDAL PYRAZOLE COMPOUNDS | BASF SE (DE) | 2013-10-24 | — | — | WO | claimed |
| US-20130125267-A1 | Pesticidal Mixtures | BASF SE (DE) | 2013-05-16 | — | — | US | claimed |
| EP-2575471-A1 | PESTICIDAL MIXTURES | BASF SE (DE) | 2013-04-10 | — | — | EP | claimed |
| US-20130012386-A1 | Methods For Controlling Pests | BASF CORPORATION (US) | 2013-01-10 | — | — | US | claimed |
| WO-2012084670-A1 | PESTICIDAL ACTIVE MIXTURES COMPRISING PYRAZOLE COMPOUNDS | BASF SE (DE) | 2012-06-28 | — | — | WO | claimed |
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | BASF CORPORATION (US) | 2012-06-14 | — | — | US | claimed |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | BASF CORPORATION (US) | 2010-12-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149570-A1 | Foamable Pesticide Compositions And Methods Of Application | DDT, PLD1, ACHE | EGLN1 1702/4885NPC1 1120/4885RAB9A 674/4885 |
| US-20100323897-A1 | FOAMABLE PESTICIDE COMPOSITIONS | DDT, PON1, ACHE | EGLN1 1382/4885NPC1 1318/4885RAB9A 1110/4885 |
| US-20130012386-A1 | Methods For Controlling Pests | DDT, ACHE, PON1 | EGLN1 1019/4885NPC1 627/4885RAB9A 557/4885 |
| US-20130125267-A1 | Pesticidal Mixtures | DDT, CYP4B1, CYP4X1 | EGLN1 930/4885NPC1 4332/4885RAB9A 934/4885 |
| US-20100322990-A1 | METHODS FOR CONTROLLING PESTS | DDT, ACHE, PON1 | EGLN1 1019/4885NPC1 627/4885RAB9A 557/4885 |
| US-20100322892-A1 | PESTICIDE COMPOSITIONS AND APPLICATORS | DDT, ACHE, CHRM2 | EGLN1 3248/4885NPC1 1127/4885RAB9A 2225/4885 |
| US-20150105258-A1 | Methods For Controlling Pests | DDT, ACHE, PON1 | EGLN1 1019/4885NPC1 627/4885RAB9A 557/4885 |
| US-20160219872-A1 | Foamable Pesticide Compositions And Methods Of Application | DDT, PLD1, ACHE | EGLN1 1702/4885NPC1 1120/4885RAB9A 674/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.